| 1 |
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. Ca A Cancer Journal for Clinicians, 2015, 65(2): 87-108.
|
| 2 |
Kitano S, Iso Y, Moriyama M, et al. Laparoscopy-assisted billroth i gastrectomy[J]. Surgical Laparoscopy Endoscopy, 1994, 4(2): 146-148.
|
| 3 |
Katai H, Sasako M, Fukuda H, et al. Safety and feasibility of laparoscopy-assisted distal gastrectomy with suprapancreatic nodal dissection for clinical stage i gastric cancer: a multicenter phase ii trial (JCOG 0703)[J]. Gastric Cancer, 2010, 13(4): 238-244.
|
| 4 |
Kim HH, Hyung WJ, Cho GS, et al. Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim report-a phase iii multicenter, prospective, randomized trial (KLASS Trial)[J]. Annals of Surgery, 2010, 251(3): 417-420.
|
| 5 |
Hu Y, Huang C, Sun Y, et al. Morbidity and mortality of laparoscopic versus open d2 distal gastrectomy for advanced gastric cancer: a randomized controlled trial[J]. Journal of Clinical Oncology Official Journal of the American Society of Clinical Oncology, 2016, 34(12): 1350-1357.
|
| 6 |
Hur H, Lee HY, Lee HJ, et al. Efficacy of laparoscopic subtotal gastrectomy with D2 lymphadenectomy for locally advanced gastric cancer: the protocol of the klass-02 multicenter randomized controlled clinical trial[J]. Bmc Cancer, 2015, 15(1): 355.
|
| 7 |
Gunderson LL. Gastric cancer-patterns of relapse after surgical resection[C]// Seminars in radiation oncology. semin radiat oncol, 2002，12(2)：150-161.
|
| 8 |
Wood DE. National comprehensive cancer network (NCCN) Clinical practice guidelines for lung cancer screening[J]. Thoracic Surgery Clinics, 2015, 25(2): 185.
|
| 9 |
Waddell T, Verheij M, Allum W, et al. Gastric cancer: esmo-esso-estro clinical practice guidelines for diagnosis, treatment and follow-up[J]. European Journal of Surgical Oncology, 2014, 40(5): 584-591.
|
| 10 |
Association JGC. Japanese gastric cancer treatment guidelines 2010 (ver. 3)[J]. Gastric Cancer, 2011, 14(2): 113-123.
|
| 11 |
Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer[J]. The New England journal of medicine，2006，355(1): 11-20.
|
| 12 |
Li ZY, Koh CE, Bu ZD, et al. Neoadjuvant chemotherapy with folfox: improved outcomes in chinese patients with locally advanced gastric cancer[J]. J Surg Oncol, 2012，105(8): 793-799.
|
| 13 |
Li ZY, Fei S, Zhang LH, et al. Complications after radical gastrectomy following folfox7 neoadjuvant chemotherapy for gastric cancer[J]. World Journal of Surgical Oncology, 2011, 9(1): 110.
|
| 14 |
Li Z, Shan F, Wang Y, et al. Laparoscopic versus open distal gastrectomy for locally advanced gastric cancer after neoadjuvant chemotherapy: safety and short-term oncologic results[J]. Surgical Endoscopy, 2016, 30(10): 1-7.
|
| 15 |
Yoshikawa T, Fukunaga T, Taguri M, et al. Laparoscopic or open distal gastrectomy after neoadjuvant chemotherapy for operable gastric cancer, a randomized phase ii trial (LANDSCOPE trial)[J]. Japanese Journal of Clinical Oncology, 2012, 42(7): 654-657.
|
| 16 |
Straatman J, Van d WN, Cuesta MA, et al. Surgical techniques, open versus minimally invasive gastrectomy after chemotherapy (STOMACH trial): study protocol for a randomized controlled trial[J]. Trials, 2015, 16(1): 123.
|